Zobrazeno 1 - 10
of 61 159
pro vyhledávání: ''
Publikováno v:
BMJ case reports. 14(10)
Induction of remission in biologic-experienced individuals with moderate to severe Crohn’s disease (CD) can be a challenge. We hereby present a case of CD with secondary non-response to infliximab. Adding methotrexate and switching to ustekinumab p
Autor:
David W. Schmidtke, S. George, Douglas A. Horstmanshof, Hendra Setiadi, Aly El-Banayosy, James W. Long, Ahmed M. El-Banayosy
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 68(8)
Infection is a serious adverse event limiting left ventricular assist device (LVAD) therapy in advanced heart failure patients, but a reliable means to identify patients at increased risk of infection is still lacking. We hypothesized that preoperati
Publikováno v:
European Journal of Surgical Oncology. 48:1799-1806
Background: The aim was to assess the likelihood of patients with simultaneously diagnosed liver and lung metastases (SLLM) from colorectal cancer (CRC) to receive the curative treatment decided upon multidisciplinary team meeting (MDT) and to elabor
Autor:
Jianwei Zhang, Yan Liu, Yong Zhu, Hong Li, Huagang Zhu, Yingxin Zhao, Ang Gao, Hongya Han, Maolin Chen, Xiangyun Kong, Kesen Liu
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 29:1226-1235
Aim Recently, the atherogenic index of plasma (AIP) has been proposed as a novel, reliable plasma atherogenicity marker. This study aimed to investigate the association of AIP with the risk of in-stent restenosis (ISR) in patients with acute coronary
Publikováno v:
Diabetes & Metabolism Journal. 46:658-662
Sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) are novel anti-diabetic drugs whose glucose-lowering effect and cardiovascular and renal benefits were evidenced in clinical trials. We investiga
Autor:
Hyun Ae Jung, Hye Ryeon Kim, Sehhoon Park, Se-Hoon Lee, Man Ki Chung, Myung-Ju Ahn, Han-Sin Jeong, Su Jin Lee
Publikováno v:
Cancer Research and Treatment. 54:719-727
Purpose Salivary gland cancers (SGCs) are relatively rare but comprise various histologic subtypes, which complicates design of prospective trials. Systemic chemotherapy plays a limited role in treatment of SGCs, but cisplatin and docetaxel showed ef
Autor:
Antonino Granata, Fabio Tuzzolino, Giovanni Lombardi, Dario Ligresti, Mario Traina, Alberto Martino
Publikováno v:
Digestive and Liver Disease. 54:729-736
Background Exposed endoscopic full-thickness resection (Eo-EFTR) is emerging as a promising minimally invasive alternative to surgery for the treatment of deep gastric submucosal tumors (G-SMTs). However, literature concerning this subject is heterog
Publikováno v:
The Surgeon. 20:137-141
Background and objectives Weight loss is the mainstay of management for women with polycystic ovarian syndrome (PCOS). However, lifestyle and dietary modifications, and gastric banding have generally poor long-term efficacy. We aimed to investigate w
Autor:
Lida Sadeghifard, Ramin Yaghobi, Mohammad Hossein Karimi, Mozhdeh Heidari, Seyed Ali Malek-Hosseini
Publikováno v:
Experimental and Clinical Transplantation. 20:564-568
OBJECTIVES Vascular endothelial growth factor is an endothelial-specific growth factor that promotes endothelial cell proliferation, differentiation, and survival; mediates endothelium-dependent vasodilatation; induces microvascular hyperpermeability
Publikováno v:
Medicina Clínica. 158:596-602
Background There is no a unified opinion in the treatment of IgA nephropathy. This prospective cohort study was to explore the effectiveness and safety of tacrolimus for treatment of IgA (Immunoglobulin A) nephropathy patients. Methods In this study,